WithdrawnNot Applicable

Microvascular Breast Reconstruction With Lymph Node Transfer

Stopped: surgery considered elective and cant be performed within corona restrictions

0Started 2021-01

Plain-language summary

this study aims to evaluate the outcomes of simultaneous free abdominal flap \& vascularized lymph node transfer for both breast reconstruction and postmastectomy lymphedema

Who can participate

Age range20 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients of 20-65 years old * Patients seeking autologous breast reconstruction and complain of clinically diagnosed arm lymphedema * Deficient lymphatic drainage on lymphoscintigraphy * Stage II and III Lymphedema * no active cellulitis * more than 12 months of follow-up Exclusion Criteria: * Females \< 20 or \>65 years old * distant metastasis * brachial plexus neuritis. * Patients with unhealthy and obstructed recipient veins or congestive heart disease with limited venous return may not be a suitable candidate for the procedure.

What they're measuring

Change in upper limb volume

Timeframe: 6-12 months

Change in lymphatic flow

Timeframe: 6-12 months

Trial details

NCT IDNCT04246034

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01

View on ClinicalTrials.gov More Lymphedema trials